A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish heahhcare setting

查看全文 作　　者：McCullagh L; Tilson L; Walsh C; 出　　处：《2009, 27 : 829 - 846》索引2009年第27卷,共0页